Jacobs Levy Equity Management, Inc Pulmonx Corp Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 83,370 shares of LUNG stock, worth $581,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,370
Previous 301,361
72.34%
Holding current value
$581,088
Previous $2.5 Million
77.34%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$38.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$21.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$15.9 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$10.7 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $260M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...